Enzymatica strengthens its management team with two new senior appointments
Joakim Tingström Nordin and Bjarki Stefánsson join to combine commercial and biotechnology expertise for accelerated international growth.
See the latest news and media coverage for Enzymatica. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of enzyme-based solutions against viruses, irritants, and microorganisms
enzymatica.comLast updated
In short: Enzymatica appointed Sana Alajmovic as CEO, signed a distribution deal with STADA, and reported Q2 2026 sales of SEK 7.1 million.
Joakim Tingström Nordin and Bjarki Stefánsson join to combine commercial and biotechnology expertise for accelerated international growth.
Net sales fell to SEK 7.1 million, with operating loss improved to SEK -12.6 million.
The notice concerns presentation of exploratory analyses in the 2023 Berlin II article, not study conduct or data validity.
Joakim Tingström Nordin will focus on strengthening ColdZyme's visibility and availability ahead of the cold season.
Enzymatica publ AB will release its next earnings report on Oct 29, 2026.
Second quarter· Net sales reached SEK 7,1 (8.3) million.· The operating result totaled SEK -12.6 (-14.9) million.· Earnings per share, basic and diluted, were SEK...
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail...
The agreement marks an important breakthrough for Enzymatica and opens opportunities in one of Europe's largest self-care markets. Net sales for the quarter amounted to...
Track Enzymatica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Enzymatica and other trending companies.